Lawyers claim that manufacturers failed to provide adequate warnings about the risks of severe complications, including gastroparesis, pancreatitis, and organ failure
Neither cohort had aspiration events and there were no significant differences in patient-reported outcomes using the Hip Disability and Osteoarthritis Outcome Score for Joint Replacement, according to Strecker
The study, Medicaid Coverage and Prior Authorization for Antiobesity Glucagon-Like Peptide-1 Receptor Agonists: A Cross- Sectional Study of State Policies, was published on November 21, 2025 in the Journal of General Internal Medicine
GHK-Cu was originally characterized for its liver-protective effects, and glutathione metabolism runs through the liver both reasons to know where hepatic biomarkers stand before introducing either compound
The truth is, weight and blood sugar management can be difficult if youve lived with diabetes, overweight, or obesity for a long time
Diarrhea on Mounjaro occurs because the medication affects how your intestines absorb water and move contents through your digestive tract